Your dog may be eligible to
participate in an important clinical study
for dogs with painful arthritis.
You may notice changes in your dog’s behavior, such as:
Any one of these behaviors can be an indication that your dog is in pain, and should be discussed with your veterinarian.
Even younger dogs can develop arthritis, particularly athletic dogs or dogs that have had a joint injury. Veterinary medicine is recognizing the early signs of arthritis in pets and seeking ways to slow the progression of the disease to help ensure pets can live long and active lives.
Just like new medications for people, new drugs for dogs must be tested for safety and effectiveness. Extensive safety studies of the test medication are already completed. This specific study is regulated by the US Food and Drug Administration (FDA) and will evaluate effectiveness and the duration of effectiveness of a potential new injectable treatment for arthritis in dogs.
Your veterinarian will help you schedule an appointment for a preliminary evaluation of your dog with the clinical investigator (a veterinarian) in your area. You can search for an investigator by zip code by clicking here.
As with any medical treatment, there are risks and benefits. The study investigator will cover these with you at the preliminary evaluation.
No. Costs for all tests and treatments required for the study are paid by the study’s sponsor.
Dogs will be randomly assigned to receive either the test medication or a placebo; however, twice as many dogs will receive the test medication as receive placebo. Neither you nor the study investigator (veterinarian) will know whether your dog is receiving the test medication or the placebo.
You must be willing to take your dog to the study investigator’s hospital for scheduled visits once per week for up to nine weeks.
Your veterinarian will give you the name, address, and phone number for the Study Investigator’s hospital.
Dogs may be considered for enrollment if they: